Co-Author
This page shows the publications co-authored by Gaurav Gaiha and Vivek Naranbhai.
Connection Strength
3.685
-
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell. 2022 Mar 31; 185(7):1259.
Score: 0.995
-
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell. 2022 03 17; 185(6):1041-1051.e6.
Score: 0.985
-
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals. medRxiv. 2022 Jan 05.
Score: 0.979
-
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines. J Infect Dis. 2022 Apr 01; 225(7):1141-1150.
Score: 0.249
-
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines. medRxiv. 2021 Oct 13.
Score: 0.241
-
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell. 2021 08 19; 184(17):4401-4413.e10.
Score: 0.236
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.